Neurogene (NGNE) Other Accumulated Expenses (2013 - 2022)

Neurogene has reported Other Accumulated Expenses for 7 years, with the latest figure at $1.2 million in Q4 2022.

• For the quarter ending Q4 2022, Other Accumulated Expenses fell 4.65% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2022 stood at $1.2 million (down 4.65% YoY), and the FY2022 full-year result was $1.2 million, down 4.65% from the prior year.
• Other Accumulated Expenses for Q4 2022 stood at $1.2 million, down from $1.2 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $1.2 million in Q4 2021, with the low at $240000.0 in Q4 2018.
• Historically, Other Accumulated Expenses has averaged $780600.0 across 5 years, with a median of $927000.0 in 2020.
• Annual changes were most pronounced in 2020 — Other Accumulated Expenses jumped 173.45% — and 2022, when it fell 4.65%.
• Neurogene's Other Accumulated Expenses stood at $240000.0 in 2018, then surged by 41.25% to $339000.0 in 2019, then jumped by 173.45% to $927000.0 in 2020, then jumped by 32.36% to $1.2 million in 2021, then fell by 4.65% to $1.2 million in 2022.
• The last three Other Accumulated Expenses figures came in at $1.2 million (Q4 2022), $1.2 million (Q4 2021), and $927000.0 (Q4 2020), per Business Quant data.